Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05875857 · ClinicalTrials.gov registry record · NA
Patient Utilization of Opioid Destruction Bags in the Post-op Period
A NA study of Opioid Use and Total Hip Arthroplasty, sponsored by University of Nebraska.
- Active
- Registry status
- NA
- Development phase
- 163
- Enrollment target
- 1
- Study location
NCT05875857 is a NA study of Opioid Use and Total Hip Arthroplasty that is active but no longer recruiting, run by University of Nebraska. The registered enrollment target is 163 participants, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05875857, a NA study of Opioid Use and Total Hip Arthroplasty, is active but no longer recruiting, sponsored by University of Nebraska.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 163 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study on how patients use and store opioid pain medications at home after surgery and what happens to left over pills when patients are done taking them. Participants will be taught the proper storage and destruction of opioid pain medications, then contacted in 6-8 weeks about pain medication used, stored disposed of.
Conditions Studied
Interventions
- BEHAVIORAL Opioid destruction education
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2023-06-19 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05875857
The ClinicalTrials.gov registry entry for NCT05875857 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which Opioid destruction education is the first listed.
NCT05875857 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT05875857 about?
NCT05875857 is a clinical study titled "Patient Utilization of Opioid Destruction Bags in the Post-op Period". This is a study on how patients use and store opioid pain medications at home after surgery and what happens to left over pills when patients are done taking them. Participants will be taught the proper storage and destruction of opioid pain medications, then contacted in 6-8 weeks about pain medica...
What is the current status of trial NCT05875857?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 163 participants. The study started on 2023-06-19. Estimated completion is 2027-01.
What conditions does trial NCT05875857 study?
This clinical trial studies the following conditions: Opioid Use, Total Hip Arthroplasty, Opioid Use, Unspecified, Patient Empowerment, Total Knee Arthoplasty.
What interventions are being tested in trial NCT05875857?
The interventions under investigation include: Opioid destruction education (BEHAVIORAL).
Who is sponsoring clinical trial NCT05875857?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05875857 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
Hip Arthroscopy Postoperative Opioid Demands
RECRUITING · NA
-
Neuroimaging of Opioid Phase (OPAL)
RECRUITING · NA
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.